| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 56.714 | 59.054 | 74.167 | 110.330 | 161.444 |
| Total Income - EUR | - | - | - | - | - | 57.617 | 59.054 | 74.291 | 112.969 | 170.692 |
| Total Expenses - EUR | - | - | - | - | - | 5.751 | 4.698 | 9.061 | 47.924 | 84.366 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 51.865 | 54.356 | 65.230 | 65.045 | 86.326 |
| Net Profit/Loss - EUR | - | - | - | - | - | 50.362 | 52.620 | 64.131 | 64.188 | 81.973 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Diabnutrimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 104.280 | 156.892 | 215.790 |
| Current Assets | - | - | - | - | - | 60.095 | 117.182 | 68.698 | 77.748 | 201.318 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 8.381 | 0 |
| Receivables | - | - | - | - | - | 2.412 | 940 | 1.501 | 8.102 | 81.555 |
| Cash | - | - | - | - | - | 57.683 | 116.242 | 67.197 | 61.265 | 119.763 |
| Shareholders Funds | - | - | - | - | - | 58.994 | 110.305 | 134.224 | 177.788 | 86.050 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.101 | 6.877 | 38.754 | 56.852 | 331.058 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabnutrimed S.r.l.